These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29546654)
21. The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Lihn AS; Pedersen SB; Lund S; Richelsen B Mol Cell Endocrinol; 2008 Sep; 292(1-2):36-41. PubMed ID: 18606210 [TBL] [Abstract][Full Text] [Related]
22. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611 [TBL] [Abstract][Full Text] [Related]
23. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR). Zhuge J Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182 [TBL] [Abstract][Full Text] [Related]
24. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase. Sauer H; Engel S; Milosevic N; Sharifpanah F; Wartenberg M Int J Oncol; 2012 Feb; 40(2):501-8. PubMed ID: 22002081 [TBL] [Abstract][Full Text] [Related]
25. AMPK activator AICAR promotes 5-FU-induced apoptosis in gastric cancer cells. Wu Y; Qi Y; Liu H; Wang X; Zhu H; Wang Z Mol Cell Biochem; 2016 Jan; 411(1-2):299-305. PubMed ID: 26497305 [TBL] [Abstract][Full Text] [Related]
26. Anti-Tumorigenic Potential of a Novel Orlistat-AICAR Combination in Prostate Cancer Cells. Wright C; Iyer AKV; Kaushik V; Azad N J Cell Biochem; 2017 Nov; 118(11):3834-3845. PubMed ID: 28387458 [TBL] [Abstract][Full Text] [Related]
27. Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells. Tulipano G; Faggi L; Losa M; Mortini P; Spinello M; Sibilia V; Pagani F; Cocchi D; Giustina A Mol Cell Endocrinol; 2013 Jan; 365(2):197-206. PubMed ID: 23116772 [TBL] [Abstract][Full Text] [Related]
28. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8. Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042 [TBL] [Abstract][Full Text] [Related]
30. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK. Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902 [TBL] [Abstract][Full Text] [Related]
31. Treatment with AICAR inhibits blastocyst development, trophectoderm differentiation and tight junction formation and function in mice. Calder MD; Edwards NA; Betts DH; Watson AJ Mol Hum Reprod; 2017 Nov; 23(11):771-785. PubMed ID: 28962017 [TBL] [Abstract][Full Text] [Related]
32. [Effect of AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleoside on proliferation, differentiation and apoptosis in U937 cells]. Lü C; Cao J; Meng FJ; Zeng LY; Chen C; Wu QY; Xu KL Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):153-6. PubMed ID: 23611224 [TBL] [Abstract][Full Text] [Related]
33. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. Jia F; Wu C; Chen Z; Lu G Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964 [TBL] [Abstract][Full Text] [Related]
34. Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells. Matoba R; Morizane Y; Shiode Y; Hirano M; Doi S; Toshima S; Araki R; Hosogi M; Yonezawa T; Shiraga F PLoS One; 2017; 12(7):e0181481. PubMed ID: 28719670 [TBL] [Abstract][Full Text] [Related]
35. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020 [TBL] [Abstract][Full Text] [Related]
36. DACH1 inhibits the proliferation and migration of papillary thyroid carcinoma. Liang S; Xu Q; Liu B; Hu R; Lai J; Wang W; Yu X; Gou J; Wang L; Chen Y; Ji Q; Zhou J Cell Biol Int; 2023 Mar; 47(3):612-621. PubMed ID: 36511182 [TBL] [Abstract][Full Text] [Related]
37. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration. Sloot YJE; Rabold K; Ulas T; De Graaf DM; Heinhuis B; Händler K; Schultze JL; Netea MG; Smit JWA; Joosten LAB; Netea-Maier RT Cell Oncol (Dordr); 2019 Oct; 42(5):691-703. PubMed ID: 31201646 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer. Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558 [TBL] [Abstract][Full Text] [Related]
39. AICAR induces mitochondrial apoptosis in human osteosarcoma cells through an AMPK-dependent pathway. Morishita M; Kawamoto T; Hara H; Onishi Y; Ueha T; Minoda M; Katayama E; Takemori T; Fukase N; Kurosaka M; Kuroda R; Akisue T Int J Oncol; 2017 Jan; 50(1):23-30. PubMed ID: 27878239 [TBL] [Abstract][Full Text] [Related]
40. Niclosamide induces apoptosis through mitochondrial intrinsic pathway and inhibits migration and invasion in human thyroid cancer in vitro. Yu K; Wang T; Li Y; Wang C; Wang X; Zhang M; Xie Y; Li S; An Z; Ye T Biomed Pharmacother; 2017 Aug; 92():403-411. PubMed ID: 28575805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]